Published in Br J Ophthalmol on November 01, 1998
Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. Brain (2013) 1.16
S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis. J Biol Chem (2009) 1.08
Structural and biochemical analyses of choroidal thickness in human donor eyes. Invest Ophthalmol Vis Sci (2014) 1.06
Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol (2000) 0.98
Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells. Br J Ophthalmol (2002) 0.89
Identification of novel retinal target genes of thyroid hormone in the human WERI cells by expression microarray analysis. Vision Res (2007) 0.88
Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration. Eur J Hum Genet (2013) 0.87
Histopathological comparison of eyes from patients with autosomal recessive retinitis pigmentosa caused by novel EYS mutations. Graefes Arch Clin Exp Ophthalmol (2014) 0.86
Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration. Hum Mol Genet (2014) 0.84
Molecular genetics of macular degeneration. Doc Ophthalmol (2001) 0.83
Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane. Br J Ophthalmol (2006) 0.80
Sorsby fundus dystrophy presenting with choroidal neovascularisation showing good response to steroid treatment. Br J Ophthalmol (2004) 0.79
Characterization of the gelatinase system of the laminar human optic nerve, and surrounding annulus of Bruch's membrane, choroid, and sclera. Invest Ophthalmol Vis Sci (2014) 0.79
The effect of TIMP-1 on the cone mosaic in the retina of the rat model of retinitis pigmentosa. Invest Ophthalmol Vis Sci (2014) 0.79
Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism. Br J Ophthalmol (2001) 0.79
Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy. Mol Vis (2009) 0.78
Retinal histopathology in eyes from patients with autosomal dominant retinitis pigmentosa caused by rhodopsin mutations. Graefes Arch Clin Exp Ophthalmol (2015) 0.77
Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase. Trans Am Ophthalmol Soc (2002) 0.76
Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3. Br J Ophthalmol (2007) 0.76
Timp-3 deficiency impairs cognitive function in mice. Lab Invest (2009) 0.76
Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy. J Clin Med (2015) 0.75
Drusen in patient-derived hiPSC-RPE models of macular dystrophies. Proc Natl Acad Sci U S A (2017) 0.75
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem (1995) 5.57
Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res (1998) 3.18
Preservation of the inner retina in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol (1997) 3.12
Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet (1994) 3.11
Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa. Arch Ophthalmol (1992) 2.94
A fundus dystrophy with unusual features. Br J Ophthalmol (1949) 2.49
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci (1997) 2.28
The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem (1995) 1.70
A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem (1992) 1.61
Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem (1995) 1.50
Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat Genet (1995) 1.50
Histopathology of bone spicule pigmentation in retinitis pigmentosa. Ophthalmology (1995) 1.45
Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics (1994) 1.44
Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology (1989) 1.38
Autosomal dominant retinitis pigmentosa caused by the threonine-17-methionine rhodopsin mutation: retinal histopathology and immunocytochemistry. Exp Eye Res (1994) 1.31
Retinal hemodynamics in retinitis pigmentosa. Am J Ophthalmol (1996) 1.30
Sorsby's fundus dystrophy. A clinical study. Ophthalmology (1989) 1.30
A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features. Hum Mol Genet (1995) 1.27
Abnormal dark adaptation and rhodopsin kinetics in Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (1992) 1.19
Sub-retinal pigment epithelial deposits in a dominant late-onset retinal degeneration. Invest Ophthalmol Vis Sci (1996) 1.18
Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1996) 1.13
Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J Pathol (1997) 1.10
Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci (1997) 1.10
Sorsby's fundus dystrophy in the British Isles: demonstration of a striking founder effect by microsatellite-generated haplotypes. Genome Res (1996) 1.08
Sorsby's pseudoinflammatory macula dystrophy--Sorsby's fundus dystrophies. Eye (Lond) (1988) 1.00
TIMP-3 is expressed in the human retinal pigment epithelium. Biochem Biophys Res Commun (1996) 0.97
Sorsby fundus dystrophy. A family with the Ser181Cys mutation of the tissue inhibitor of metalloproteinases 3. Arch Ophthalmol (1996) 0.94
Sorsby's fundus dystrophy. A South African family with a point mutation on the tissue inhibitor of metalloproteinases-3 gene on chromosome 22. Retina (1995) 0.92
Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr Eye Res (1997) 0.92
Expression of TIMP3 mRNA is elevated in retinas affected by simplex retinitis pigmentosa. FEBS Lett (1994) 0.91
Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance. Am J Hum Genet (1997) 0.88
Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies. Invest Ophthalmol Vis Sci (1997) 0.87
Localization of tissue inhibitor of metalloproteinases-3 in neurodegenerative retinal disease. Neuroreport (1997) 0.85
Increased expression of retinal TIMP3 mRNA in simplex retinitis pigmentosa is localized to photoreceptor-retaining regions. J Neurochem (1995) 0.82
Vitamin A megatherapy for retinal abnormalities. Nat Med (1995) 0.82
Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation. Trans Am Ophthalmol Soc (1996) 0.79
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A (2000) 4.22
Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32
Corticobasal degeneration. Brain (1989) 3.20
Preservation of the inner retina in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol (1997) 3.12
X-linked retinitis pigmentosa. Br J Ophthalmol (1975) 3.11
Tears of detached retinal pigment epithelium. Br J Ophthalmol (1981) 3.08
A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell (2001) 3.07
Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci (1998) 3.05
A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97
Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa. Arch Ophthalmol (1992) 2.94
Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol (1998) 2.89
Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet (2000) 2.82
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67
Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28. Nature (1984) 2.52
Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet (2001) 2.48
RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections. J Med Genet (2003) 2.45
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci (1997) 2.28
The development of neovascularization of senile disciform macular degeneration. Am J Ophthalmol (1973) 2.17
Recent advances in the treatment of senile disciform macular degeneration by photocoagulation. Br J Ophthalmol (1974) 2.14
In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol (1997) 2.10
Senile disciform macular degeneration in the second eye. Br J Ophthalmol (1977) 2.07
Bilateral acute retinal necrosis. Br J Ophthalmol (1978) 2.07
Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology (1994) 2.04
Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol (2001) 2.04
Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology (1990) 1.99
Distribution and morphology of human cone photoreceptors stained with anti-blue opsin. J Comp Neurol (1991) 1.98
Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol (1988) 1.90
A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Am J Hum Genet (1991) 1.88
A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (1985) 1.87
Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet (1998) 1.84
A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet (1998) 1.81
A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1992) 1.80
Multiple phosphorylated isoforms of NRL are expressed in rod photoreceptors. J Biol Chem (2001) 1.79
A mutation in NRL is associated with autosomal dominant retinitis pigmentosa. Nat Genet (1999) 1.79
Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa. Invest Ophthalmol Vis Sci (1999) 1.77
A clinical study of the vascularity of senile disciform macular degeneration. Am J Ophthalmol (1973) 1.77
Pattern of retinal dysfunction in acute zonal occult outer retinopathy. Ophthalmology (1995) 1.75
Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man. Proc Natl Acad Sci U S A (1998) 1.75
Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (1989) 1.75
Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol (1985) 1.74
Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol (2006) 1.74
Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol (2002) 1.74
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet (1994) 1.71
Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol (2005) 1.70
Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69
A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet (1993) 1.67
Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol (1990) 1.66
Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain (1987) 1.66
Drusen as risk factors in age-related macular disease. Am J Ophthalmol (1990) 1.66
Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol (1980) 1.65
Retinal macroaneurysms. Br J Ophthalmol (1975) 1.64
Retinal rod photoreceptor-specific gene mutation perturbs cone pathway development. Neuron (1999) 1.64
Retinopathy in haemoglobin C trait. Eye (Lond) (1996) 1.63
The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62
Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab (1997) 1.58
Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57
Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol (1994) 1.55
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54
Senile disciform macular degeneration: features indicating suitability for photocoagulation. Br J Ophthalmol (1979) 1.54
ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family. J Biol Chem (1999) 1.53
Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol (1993) 1.51
Rod photoreceptor neurite sprouting in retinitis pigmentosa. J Neurosci (1995) 1.51
On the retinal vasculature of the human fovea. Exp Eye Res (1974) 1.50
Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology (1994) 1.49
Low vision services for vision rehabilitation in the United Kingdom. Br J Ophthalmol (2002) 1.47
Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics (1991) 1.46
Histopathology of bone spicule pigmentation in retinitis pigmentosa. Ophthalmology (1995) 1.45
Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem (2001) 1.45
Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child (1977) 1.44
Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol (1975) 1.42
Histopathology of incipient fundus flavimaculatus. Ophthalmology (1991) 1.42
Radiotherapy for age-related macular degeneration. Clin Oncol (R Coll Radiol) (1998) 1.41
Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study. Br J Ophthalmol (1993) 1.41
A comparative histopathological study of argon and krypton laser irradiations of the human retina. Br J Ophthalmol (1979) 1.41
Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J Biol Chem (1999) 1.41
Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol (2007) 1.40
The role of molecular genetics in the prenatal diagnosis of retinal dystrophies. Eye (Lond) (1995) 1.39
Mice lacking ornithine-delta-aminotransferase have paradoxical neonatal hypoornithinaemia and retinal degeneration. Nat Genet (1995) 1.39
A linkage survey of 20 dominant retinitis pigmentosa families: frequencies of the nine known loci and evidence for further heterogeneity. J Med Genet (1998) 1.39
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology (1989) 1.38
Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. Br J Ophthalmol (1979) 1.37
Abnormalities in rod photoreceptors, amacrine cells, and horizontal cells in human retinas with retinitis pigmentosa. Am J Ophthalmol (2000) 1.36
Rhodopsin phosphorylation and dephosphorylation in vivo. J Biol Chem (1995) 1.36
Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett (1997) 1.36
Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol (1998) 1.35
Visual prognosis of disciform degeneration in myopia. Ophthalmology (1983) 1.34
Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol (1999) 1.34
Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia. Ophthalmology (2001) 1.34
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Confocal imaging of the fundus using a scanning laser ophthalmoscope. Br J Ophthalmol (1992) 1.32
Light-induced acceleration of photoreceptor degeneration in transgenic mice expressing mutant rhodopsin. Invest Ophthalmol Vis Sci (1996) 1.31